Work

Non-Relapse Mortality in Chronic Graft Versus Host Disease: Risk Factors At Onset and Reponse to Treatment

Year: 2013

Type: article

Abstract: Chronic graft versus host disease (cGVHD) is a major contributor to morbidity and mortality in long-term survivors of allogeneic hematopoietic cell transplantation (HCT). The treatment course is heterogeneous and unpredictable, and a prognostic system at the time of disease onset is highly desirable. We developed a simple system that should minimize inter-provider variability, and can be applied at disease onset. We studied 341 consecutive adult patients (age 18-71y; median 53y) who received HCT at the University of Michigan from 2007 to 2010.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2012.11.505